Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ALBT Avalon GloboCare Corp
- Stocks
- Healthcare
- NASDAQ: ALBT
Price (delayed)
$3.79
Market cap
$6.26M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$8.44
Enterprise value
$11.24M
Highlights
Avalon GloboCare's quick ratio has surged by 200% YoY and by 133% QoQ
The EPS has surged by 65% year-on-year and by 58% since the previous quarter
The equity has increased by 31% since the previous quarter but it has declined by 3.6% year-on-year
Avalon GloboCare's gross profit has increased by 12% YoY but it has decreased by 4.1% from the previous quarter
Key stats
What are the main financial stats of ALBT
Market
Valuations
Earnings
Shares outstanding
1.65M
Market cap
$6.26M
Enterprise value
$11.24M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.58
Price to sales (P/S)
2.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.43
Revenue
$1.33M
Gross profit
$267,829
Operating income
-$4.93M
Net income
-$7.9M
EBIT
-$5.47M
EBITDA
-$5.17M
Free cash flow
-$4.97M
Per share
Balance sheet
Liquidity
EPS
-$8.44
EPS diluted
-$8.44
Free cash flow per share
-$5.31
Book value per share
$6.49
Revenue per share
$1.42
TBVPS
$22.41
Total assets
$20.99M
Total liabilities
$13.88M
Debt
$7.84M
Equity
$7.1M
Working capital
-$10.65M
Debt to equity
1.1
Current ratio
0.23
Quick ratio
0.21
Net debt/EBITDA
-0.96
Margins
Efficiency
Dividend
EBITDA margin
-387.4%
Gross margin
20.1%
Net margin
-592.7%
Operating margin
-369.6%
Return on assets
-39.3%
Return on equity
-137.6%
Return on invested capital
-32.8%
Return on capital employed
-77%
Return on sales
-410%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALBT stock price
How has the Avalon GloboCare stock price performed over time
Intraday
-2.07%
1 week
4.41%
1 month
1.88%
1 year
-17.25%
YTD
16.26%
QTD
-21.04%
Financial performance
How have Avalon GloboCare's revenue and profit performed over time
Revenue
$1.33M
Gross profit
$267,829
Operating income
-$4.93M
Net income
-$7.9M
Gross margin
20.1%
Net margin
-592.7%
ALBT's operating margin has surged by 71% year-on-year and by 64% since the previous quarter
ALBT's operating income has surged by 69% year-on-year and by 63% since the previous quarter
The company's net margin has surged by 55% YoY and by 47% QoQ
The net income has soared by 53% YoY and by 46% from the previous quarter
Price vs fundamentals
How does ALBT's price correlate with its fundamentals
Growth
What is Avalon GloboCare's growth rate over time
Valuation
What is Avalon GloboCare stock price valuation
P/E
N/A
P/B
0.58
P/S
2.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.43
The EPS has surged by 65% year-on-year and by 58% since the previous quarter
The stock's price to book (P/B) is 98% less than its 5-year quarterly average of 26.1 and 17% less than its last 4 quarters average of 0.7
The equity has increased by 31% since the previous quarter but it has declined by 3.6% year-on-year
The stock's price to sales (P/S) is 93% less than its 5-year quarterly average of 35.9 and 5% less than its last 4 quarters average of 2.8
The revenue has grown by 6% YoY
Efficiency
How efficient is Avalon GloboCare business performance
The return on sales has surged by 66% year-on-year and by 57% since the previous quarter
ALBT's ROIC is up by 49% QoQ and by 39% YoY
ALBT's return on assets is up by 47% since the previous quarter and by 34% year-on-year
ALBT's return on equity is up by 46% since the previous quarter but it is down by 28% year-on-year
Dividends
What is ALBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALBT.
Financial health
How did Avalon GloboCare financials performed over time
The company's total assets is 51% higher than its total liabilities
Avalon GloboCare's quick ratio has surged by 200% YoY and by 133% QoQ
The current ratio has surged by 109% since the previous quarter and by 77% year-on-year
The company's debt is 10% higher than its equity
The debt to equity fell by 32% QoQ and by 4.3% YoY
The equity has increased by 31% since the previous quarter but it has declined by 3.6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.